Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00194272
Status:
COMPLETED
Last Update Posted:
2011-08-09
First Post:
2005-09-13
Brief Title:
Two-Dose Methotrexate for Ectopic Pregnancy
Sponsor:
University of Pennsylvania
Organization:
University of Pennsylvania
Study Overview
Official Title:
Two-Dose Methotrexate for Ectopic Pregnancy
Status:
COMPLETED
Status Verified Date:
2011-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study examines the safety and acceptability of a novel two dose regimen of methotrexate to treat ectopic pregnancy
Detailed Description:
The regimen is an attempt to create a middle ground between the 2 commonly used regimens - single dose and multi dose The multi dose regimen is more effective but the single dose regimen is more convenient for patients and has fewer side effects
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RRU001 | None | None | None |